Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

6.0K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.0K
Positive Regulator Molecules02:39

Positive Regulator Molecules

6.3K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

4.8K
Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
4.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.4K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

2.3K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The subpleural pulmonary microvasculature in newborn yak (Bos grunniens).

Veterinary research communications·2008
Same author

Experimental confirmation of potential swept source optical coherence tomography performance limitations.

Applied optics·2008
Same author

A germin-like protein gene family functions as a complex quantitative trait locus conferring broad-spectrum disease resistance in rice.

Plant physiology·2008
Same author

[Spatial and temporal changes of palatal cell proliferation and cell apoptosis of retinoic acid induced mouse cleft palate in different embryonic stages].

Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology·2008
Same author

Identification of an Atlantic salmon IFN multigene cluster encoding three IFN subtypes with very different expression properties.

Developmental and comparative immunology·2008
Same author

Non-Gaussian statistics and superdiffusion in a driven-dissipative dusty plasma.

Physical review. E, Statistical, nonlinear, and soft matter physics·2008

Related Experiment Video

Updated: Nov 26, 2025

Initiating Differentiation in Immortalized Multipotent Otic Progenitor Cells
12:17

Initiating Differentiation in Immortalized Multipotent Otic Progenitor Cells

Published on: January 2, 2016

8.8K

miR‑125/CDK2 axis in cochlear progenitor cell proliferation.

Tao Peng1, Jing-Jing Peng2, Gang-Yong Miao1

  • 1Department of Otolaryngology and Head and Neck Surgery, Hunan Provincial People's Hospital, First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410007, P.R. China.

Molecular Medicine Reports
|December 10, 2020
PubMed
Summary
This summary is machine-generated.

MicroRNA-125 (miR-125) inhibits cochlear progenitor cell proliferation by downregulating cyclin-dependent kinase 2 (CDK2). This finding offers a potential new therapeutic strategy for treating hearing loss.

Keywords:
miR‑125cochlear progenitor cellcyclin‑dependent kinase 2bromodeoxyuridinenestin

More Related Videos

Long-term Time Lapse Imaging of Mouse Cochlear Explants
10:43

Long-term Time Lapse Imaging of Mouse Cochlear Explants

Published on: November 2, 2014

9.9K
Isolating LacZ-expressing Cells from Mouse Inner Ear Tissues using Flow Cytometry
11:14

Isolating LacZ-expressing Cells from Mouse Inner Ear Tissues using Flow Cytometry

Published on: December 23, 2011

11.5K

Related Experiment Videos

Last Updated: Nov 26, 2025

Initiating Differentiation in Immortalized Multipotent Otic Progenitor Cells
12:17

Initiating Differentiation in Immortalized Multipotent Otic Progenitor Cells

Published on: January 2, 2016

8.8K
Long-term Time Lapse Imaging of Mouse Cochlear Explants
10:43

Long-term Time Lapse Imaging of Mouse Cochlear Explants

Published on: November 2, 2014

9.9K
Isolating LacZ-expressing Cells from Mouse Inner Ear Tissues using Flow Cytometry
11:14

Isolating LacZ-expressing Cells from Mouse Inner Ear Tissues using Flow Cytometry

Published on: December 23, 2011

11.5K

Area of Science:

  • Regenerative Medicine
  • Molecular Biology
  • Otolaryngology

Background:

  • Hearing loss is a significant global disability.
  • Hair cell regeneration through progenitor cell manipulation is a promising therapeutic avenue.
  • Understanding the molecular mechanisms regulating cochlear progenitor cell (CPC) proliferation is crucial.

Purpose of the Study:

  • To investigate the role and mechanism of microRNA-125 (miR-125) in regulating cochlear progenitor cell (CPC) proliferation.
  • To determine if miR-125 directly targets cyclin-dependent kinase 2 (CDK2).
  • To explore the potential of targeting miR-125 for hearing loss treatment.

Main Methods:

  • Isolation and characterization of CPCs from neonatal rats.
  • Assessment of CPC proliferation, differentiation, and cell cycle using immunofluorescence, flow cytometry, RT-qPCR, and western blotting.
  • Gain- and loss-of-function assays for miR-125 and CDK2, including dual luciferase reporter assays to confirm direct targeting.

Main Results:

  • CPCs formed progenitor spheres with positive expression of BrdU, nestin, and myosin VII.
  • CPC proliferation increased during in vitro incubation, with distinct expression patterns for miR-125 and CDK2.
  • miR-125 overexpression inhibited CPC proliferation by downregulating CDK2 and reducing cells in the S phase.
  • miR-125 directly targets CDK2, and simultaneous knockdown of both enhanced CPC proliferation.

Conclusions:

  • miR-125 inhibits CPC proliferation by downregulating CDK2.
  • This miR-125/CDK2 pathway represents a novel therapeutic target for hearing loss.
  • Further research into this mechanism could lead to new treatments for hearing restoration.